Alan Milburn, Health Secretary from 1998 to 2003
Alan Milburn is listed in his declaration of members’ interests at the House of Commons as a director of Covidien, which describes itself as "a $10bn global healthcare products leader". He is also a member of Lloydspharmacy’s Healthcare Advisory Panel. Milburn is an advisor to the European advisory panel of leading private equity firm Bridgepoint, which specialises in healthcare investments. Milburn declares his income from these senior appointments as over £30,000 a year from Bridgepoint; over £25,000 from Lloydspharmacy; nothing listed for Covidien; and a further over £20,000 as
23 September 2008